Glossary
Plain definitions of the medical and legal terms used across DoseUses.
- Addiction
- A treatable brain condition, also called substance use disorder, in which a person continues using a substance despite harm. Different from physical dependence.
- Agonist
- A drug that activates a receptor. Oxycodone is a full opioid agonist; buprenorphine is a partial agonist.
- Antagonist
- A drug that blocks a receptor. Naloxone is an opioid antagonist.
- Benzodiazepine
- A class of sedatives that enhance GABA, such as alprazolam and diazepam.
- Boxed warning
- The FDA's strongest label warning, printed in a black box at the top of the prescribing information.
- CNS depressant
- Any substance that slows the central nervous system, including opioids, sedatives, alcohol, and GHB. Combining them is a leading cause of overdose.
- Contingency management
- A treatment that gives rewards for drug-free tests. The most effective treatment for stimulant use disorder.
- Controlled substance
- A drug regulated under the Controlled Substances Act and placed in one of five schedules.
- CYP3A4 and CYP2D6
- Liver enzymes that break down many drugs. Medicines that block or speed them up can raise or lower drug levels.
- DEA registration
- Federal registration a clinician needs to prescribe controlled substances.
- Dependence (physical)
- The body's adaptation to a drug, so that stopping causes withdrawal. It can happen with prescribed use and is not the same as addiction.
- Dissociative
- A drug, such as ketamine or PCP, that causes feelings of detachment from the body and surroundings.
- Fentanyl test strip
- A paper strip that detects fentanyl in a drug sample. Legal in most states.
- Half-life
- The time it takes for the level of a drug in the blood to fall by half. After about five half-lives, most of a drug is gone.
- Harm reduction
- Practical strategies, such as naloxone, test strips, and syringe services, that reduce the harms of drug use.
- Naloxone
- A medicine that rapidly reverses opioid overdose. Sold without a prescription as Narcan and generics.
- Nitazenes
- A class of synthetic opioids, some stronger than fentanyl, found in counterfeit pills.
- Opioid use disorder
- Addiction to opioids. Treated most effectively with buprenorphine or methadone.
- PDMP
- Prescription drug monitoring program: a state database of controlled-substance prescriptions that clinicians and pharmacists check.
- Precipitated withdrawal
- Sudden withdrawal caused by taking buprenorphine or naloxone while full opioids are still active.
- Prodrug
- An inactive drug that the body converts into an active one, such as lisdexamfetamine to dextroamphetamine, or codeine to morphine.
- REMS
- Risk Evaluation and Mitigation Strategy: an FDA safety program that restricts how certain drugs are prescribed or dispensed.
- Schedule
- One of five categories in the Controlled Substances Act, from Schedule I (no accepted medical use) to Schedule V (lowest potential for abuse).
- Serotonin syndrome
- A dangerous excess of serotonin, causing agitation, fever, sweating, muscle twitching, and fast heartbeat, often from combining serotonergic drugs.
- Taper
- A gradual dose reduction to stop a medicine safely and minimize withdrawal.
- Telemedicine flexibilities
- Temporary federal rules allowing controlled medicines to be prescribed after a video or phone visit, extended through December 31, 2026.
- Tolerance
- Needing more of a drug to get the same effect. Tolerance falls after a break, which raises overdose risk.
- Xylazine
- A veterinary sedative found in illicit fentanyl that is not reversed by naloxone and causes severe wounds.
No terms match.